This topic contains a solution. Click here to go to the answer

Author Question: Which drug, when given concurrently with cyclosporine, can inhibit hepatic microsomal enzymes and ... (Read 24 times)

sam.t96

  • Hero Member
  • *****
  • Posts: 570
Which drug, when given concurrently with cyclosporine, can inhibit hepatic microsomal enzymes and lead to toxic levels of cyclosporine?
 
  a. Phenytoin
  b. Rifampin
  c. Erythromycin
  d. Trimethoprim-sulfamethoxazole

Question 2

Which patient can safely use ergotamine for a migraine headache?
 
  a. A woman with severe menstrual migraines
  b. A pregnant patient with severe migraines
  c. An older man with coronary artery disease
  d. An adolescent with renal insufficiency



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kjo;oj

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

c

Answer to Question 2

a




sam.t96

  • Member
  • Posts: 570
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


flexer1n1

  • Member
  • Posts: 373
Reply 3 on: Yesterday
Excellent

 

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

Did you know?

Nearly all drugs pass into human breast milk. How often a drug is taken influences the amount of drug that will pass into the milk. Medications taken 30 to 60 minutes before breastfeeding are likely to be at peak blood levels when the baby is nursing.

Did you know?

Automated pill dispensing systems have alarms to alert patients when the correct dosing time has arrived. Most systems work with many varieties of medications, so patients who are taking a variety of drugs can still be in control of their dose regimen.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library